These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 9593759)
1. Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus. Forst T; Kunt T; Pohlmann T; Goitom K; Engelbach M; Beyer J; Pfützner A J Clin Invest; 1998 May; 101(10):2036-41. PubMed ID: 9593759 [TBL] [Abstract][Full Text] [Related]
2. Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I. Forst T; De La Tour DD; Kunt T; Pfützner A; Goitom K; Pohlmann T; Schneider S; Johansson BL; Wahren J; Löbig M; Engelbach M; Beyer J; Vague P Clin Sci (Lond); 2000 Mar; 98(3):283-90. PubMed ID: 10677386 [TBL] [Abstract][Full Text] [Related]
3. Microvascular skin blood flow following the ingestion of 75 g glucose in healthy individuals. Forst T; Kunt T; Pohlmann T; Goitom K; Löbig M; Engelbach M; Beyer J; Pfützner A Exp Clin Endocrinol Diabetes; 1998; 106(6):454-9. PubMed ID: 10079023 [TBL] [Abstract][Full Text] [Related]
4. Impact of insulin on microvascular blood flow and endothelial cell function in the postprandial state in patients with Type 1 diabetes. Forst T; Forst S; Strunk K; Löbig M; Welter K; Kazda C; Pfützner A J Diabetes Complications; 2005; 19(3):128-32. PubMed ID: 15866056 [TBL] [Abstract][Full Text] [Related]
5. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate. Al-Waili N Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866 [TBL] [Abstract][Full Text] [Related]
6. C-peptide does not affect ocular blood flow in patients with type 1 diabetes. Polska E; Kolodjaschna J; Berisha F; Malec MM; Simader C; Bayerle-Eder M; Roden M; Schmetterer L Diabetes Care; 2006 Sep; 29(9):2034-8. PubMed ID: 16936149 [TBL] [Abstract][Full Text] [Related]
7. The effect of polyneuropathy on foot microcirculation in Type II diabetes. Nabuurs-Franssen MH; Houben AJ; Tooke JE; Schaper NC Diabetologia; 2002 Aug; 45(8):1164-71. PubMed ID: 12189447 [TBL] [Abstract][Full Text] [Related]
8. Blood flow in the skin of type 1 diabetic patients before and after combined pancreas/kidney transplantation. Eberl N; Piehlmeier W; Dachauer S; König A; Land W; Landgraf R Diabetes Metab Res Rev; 2005; 21(6):525-32. PubMed ID: 15880479 [TBL] [Abstract][Full Text] [Related]
9. Acute, local effects of iontophoresed insulin and C-peptide on cutaneous microvascular function in Type 1 diabetes mellitus. Delaney C; Shaw J; Day T Diabet Med; 2004 May; 21(5):428-33. PubMed ID: 15089786 [TBL] [Abstract][Full Text] [Related]
10. Effects of a short-term improvement in glycaemic control on skin microvascular dysfunction in Type 1 and Type 2 diabetic patients. Meyer MF; Rose CJ; Schatz H; Klein HH Diabet Med; 2009 Sep; 26(9):880-6. PubMed ID: 19719708 [TBL] [Abstract][Full Text] [Related]
11. The effect of an angiotensin converting enzyme inhibitor on skin microvascular hyperaemia in microalbuminuric insulin-dependent diabetes mellitus. Yosipovitch G; Schneiderman J; Erman A; Chetrit A; Milo G; Boner G; van Dijk DJ Diabet Med; 1997 Mar; 14(3):235-41. PubMed ID: 9088773 [TBL] [Abstract][Full Text] [Related]
12. Effects of C-peptide on forearm blood flow and brachial artery dilatation in patients with type 1 diabetes mellitus. Fernqvist-Forbes E; Johansson BL; Eriksson MJ Acta Physiol Scand; 2001 Jul; 172(3):159-65. PubMed ID: 11472302 [TBL] [Abstract][Full Text] [Related]
13. C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism. Johansson BL; Wahren J; Pernow J Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E864-70. PubMed ID: 12799312 [TBL] [Abstract][Full Text] [Related]
14. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients. Vilsbøll T; Krarup T; Madsbad S; Holst JJ Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441 [TBL] [Abstract][Full Text] [Related]
15. Effects of C-peptide on microvascular blood flow and blood hemorheology. Forst T; Kunt T Exp Diabesity Res; 2004; 5(1):51-64. PubMed ID: 15198371 [TBL] [Abstract][Full Text] [Related]
16. Endothelial and neural regulation of skin microvascular blood flow in patients with diabetic peripheral neuropathy: effect of treatment with the isoform-specific protein kinase C beta inhibitor, ruboxistaurin. Brooks B; Delaney-Robinson C; Molyneaux L; Yue DK J Diabetes Complications; 2008; 22(2):88-95. PubMed ID: 18280438 [TBL] [Abstract][Full Text] [Related]
17. C-peptide potentiates the vasoconstrictor effect of neuropeptide Y in insulin-dependent diabetic patients. Johansson BL; Pernow J Acta Physiol Scand; 1999 Jan; 165(1):39-44. PubMed ID: 10072095 [TBL] [Abstract][Full Text] [Related]
18. Effects of C-peptide on insulin-induced hypoglycaemia and its counterregulatory responses in IDDM patients. Oskarsson P; Johansson BL; Adamson U; Lins PE Diabet Med; 1997 Aug; 14(8):655-9. PubMed ID: 9272591 [TBL] [Abstract][Full Text] [Related]
19. Vasogen's immune modulation therapy (IMT) improves postischemic foot skin blood flow and transcutaneous pO(2) recovery rates in patients with advanced peripheral arterial occlusive disease. Edvinsson LI; Edvinsson ML; Angus Deveber G Int Angiol; 2003 Jun; 22(2):141-7. PubMed ID: 12865879 [TBL] [Abstract][Full Text] [Related]
20. The effect of alpha-lipoic acid on the neurovascular reflex arc in patients with diabetic neuropathy assessed by capillary microscopy. Haak ES; Usadel KH; Kohleisen M; Yilmaz A; Kusterer K; Haak T Microvasc Res; 1999 Jul; 58(1):28-34. PubMed ID: 10388600 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]